Pancreas Cancer

Oncology
2
Pipeline Programs
5
Companies
5
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
1100%
+ 4 programs with unclassified modality

Competitive Landscape

5 companies ranked by most advanced pipeline stage

Bayer
BayerLEVERKUSEN, Germany
1 program
1
VemurafenibPhase 2Small Molecule1 trial
Active Trials
NCT05068752Active Not Recruiting12Est. Dec 2024
Novartis
NovartisBASEL, Switzerland
1 program
1
FOLFIRINOXPhase 11 trial
Active Trials
NCT05417386Terminated4Est. Jul 2023
HistoSonics
HistoSonicsMI - Ann Arbor
1 program
HistoSonics Edison™ System for the treatment of pancreatic adenocarcinoma using histotripsyN/A1 trial
Active Trials
NCT06282809Recruiting50Est. Jan 2027
Varian Medical Systems
1 program
Stereotactic Body RadiotherapyN/A1 trial
Active Trials
NCT05043857Active Not RecruitingEst. Jul 2025
Verona Pharma
Verona PharmaUK - London
1 program
Systematic lymphadenectomyN/A1 trial
Active Trials
NCT06135649Unknown850Est. Dec 2024

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
BayerVemurafenib
NovartisFOLFIRINOX
HistoSonicsHistoSonics Edison™ System for the treatment of pancreatic adenocarcinoma using histotripsy
Varian Medical SystemsStereotactic Body Radiotherapy
Verona PharmaSystematic lymphadenectomy

Clinical Trials (5)

Total enrollment: 916 patients across 5 trials

NCT05068752BayerVemurafenib

Phase II Trial of Vemurafenib and Sorafenib in Pancreatic Cancer

Start: Oct 2021Est. completion: Dec 202412 patients
Phase 2Active Not Recruiting
NCT05417386NovartisFOLFIRINOX

FOLFIRINOX + NIS793 in Pancreatic Cancer

Start: Aug 2022Est. completion: Jul 20234 patients
Phase 1Terminated
NCT06282809HistoSonicsHistoSonics Edison™ System for the treatment of pancreatic adenocarcinoma using histotripsy

The HistoSonics Edison™ System for Treatment of Pancreatic Adenocarcinoma Using Histotripsy

Start: Dec 2024Est. completion: Jan 202750 patients
N/ARecruiting
NCT05043857Varian Medical SystemsStereotactic Body Radiotherapy

Stereotactic PAncreatic RadioTherapy Adjuvant Therapy

Start: Jul 2021Est. completion: Jul 2025
N/AActive Not Recruiting
NCT06135649Verona PharmaSystematic lymphadenectomy

Dissecting the Pattern of Nodal Spread in Post-neoadjuvant Pancreatoduodenectomy

Start: Jan 2013Est. completion: Dec 2024850 patients
N/AUnknown

Related Jobs in Oncology

Senior Research Associate, Immuno-Oncology

SystImmune
1h ago
$60K - $85K/yr

Research Associate I/II, Immuno-Oncology

SystImmune
1h ago

Office Administrator

SystImmune
1h ago
$60K - $80K/yr

Scientist/Sr Scientist

TwoStep Therapeutics
San Carlos
1h ago

Senior Medical Project Manager (m/f/d)

Mindpeak
Hamburg
1h ago

Working Student Active Sourcing Support (m/f/d)

Mindpeak
Hamburg
1h ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 916 patients
5 companies competing in this space

Related Indications

Breast Cancer(530)Non-small Cell Lung Cancer(373)Prostate Cancer(371)Multiple Myeloma(244)Advanced Solid Tumors(221)Acute Myeloid Leukemia(204)Cancer(187)Neoplasms(173)Colorectal Cancer(166)Advanced Solid Tumor(165)